TABLE 3.
Peptide | Reactivitya with serum or primary antibody (SN titer, ELISA S/P ratio)b:
|
||||||
---|---|---|---|---|---|---|---|
6 (64, 1.053) | 8 (128, 1.712) | 3 (64, 1.835) | 5 (64, 1.677) | 19 (<4, <0.4) | ISU19-A1 (<2, 0.441) | ISU25-C1 (8, 0.190) | |
S1 (epitopes A and B) VLVNANNSSSSHFQSIYNC | 1.780 (± 0.045) | 0.503 (± 0.011) | 0.626 (± 0.006) | 0.720 (± 0.013) | 0.099 (± 0.008) | 0.020 (± 0.001) | −0.014 (± 0.014) |
S2 (epitope A removed, epitope B present) SGSGA NNSSSSHFQSIYNC | 0.152 (± 0.033) | 0.189 (± 0.019) | 0.284 (± 0.002) | 0.051 (± 0.001) | 0.036 (± 0.006) | 0.013 (± 0.005) | −0.023 (± 0.000) |
S3 (epitopes A and B removed) SGSGANNSSSSGS GSIYNC | 0.005 (± 0.021) | 0.092 (± 0.002) | 0.161 (± 0.014) | 0.019 (± 0.014) | 0.020 (± 0.011) | 0.017 (± 0.009) | −0.054 (± 0.399) |
S4 (mimotope B) SHITSYHPAYFWC | −0.004 (± 0.014) | −0.185 (± 0.001) | −0.161 (± 0.001) | −0.09 (± 0.003) | −0.100 (± 0.001) | 0.037 (± 0.002) | 1.811 (± 0.014) |
R4N (mimotope A) ALVNIPISNNLAC | 1.784 (± 0.022) | 0.599 (± 0.004) | 1.061 (± 0.003) | 1.205 (± 0.018) | 0.211 (± 0.002) | 0.041 (± 0.006) | −0.04 (± 0.031) |
R1N (epitope A) VLVNSNNSSSSAC | 1.679 (± 0.085) | 0.653 (± 0.005) | 0.753 (± 0.016) | 0.716 (± 0.011) | 0.177 (± 0.001) | 0.094 (± 0.058) | −0.001 (± 0.006) |
Δ4R1N (epitope A removed) SGSGSNNSSSSAC | −0.010 (± 0.021) | 0.123 (± 0.016) | 0.174 (± 0.001) | 0.010 (± 0.006) | −0.033 (± 0.018) | −0.007 (± 0.008) | −0.031 (± 0.002) |
Results are expressed as corrected OD at 405 nm (OD for selected phage − OD for unselected phage library) (± standard deviation).
SN titer was determined against the PRRSV Iowa strain. ELISA S/P ratio was determined as described in Materials and Methods. Sera 3, 5, 6, and 8 are from PRRSV-hyperimmunized pigs, serum 19 is a negative control (see Materials and Methods), ISU25-C1 and ISU19-A1 are anti-PRRSV neutralizing and nonneutralizing MAbs, respectively.